Related Experiment Video
Updated: May 29, 2025

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
The Role of Small Extracellular Vesicles in Retinoblastoma Development and Progression
Jyothi Attem1, Geeta K Vemuganti1
1School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad, India.
Abstract:
A growing body of research on extracellular vesicles (EVs) in cancer has revealed their novel and crucial activities in the progression of tumors while also paving the way for potential therapeutic interventions. It is now known that EVs are natural delivery vehicles for particular payloads of source cells, enabling them to influence diverse functions of cells both in healthy and malignant cells. In this review, we comprehensively summarize mechanistic insights into sEV roles in RB, the most frequent intraocular malignancy that affects the retina of young children. We also explore the therapeutic potential of sEVs as an emerging area as biomarkers and vehicles for targeted therapy. Additionally, we address the potential challenges and limitations of translating sEVs-based technologies into clinical practice.
Insights
Extracellular vesicles (EVs) are key players in cancer progression and offer therapeutic potential. This review details small EVs (sEVs) roles in retinoblastoma (RB) and their clinical translation challenges.
Area of Science:
- Oncology
- Cell Biology
- Ophthalmology
Background:
- Extracellular vesicles (EVs) are increasingly recognized for their roles in cancer progression.
- EVs act as natural delivery vehicles, influencing cell functions.
- Small EVs (sEVs) are particularly important in tumor biology.
Purpose of the Study:
- To review the mechanistic roles of sEVs in retinoblastoma (RB), a common childhood intraocular malignancy.
- To explore the therapeutic potential of sEVs in RB as biomarkers and drug delivery vehicles.
- To address challenges in translating sEV-based technologies for clinical use.
Main Methods:
- Comprehensive literature review of existing research on EVs and RB.
- Analysis of mechanistic insights into sEV functions in retinoblastoma.
- Evaluation of current and future therapeutic applications of sEVs.
Main Results:
- sEVs play significant roles in the progression of retinoblastoma.
- sEVs show promise as biomarkers for early detection and monitoring of RB.
- sEVs can be engineered for targeted delivery of therapeutic agents to retinoblastoma cells.
Conclusions:
- Understanding sEV mechanisms in RB is crucial for developing novel therapies.
- sEVs offer a promising avenue for targeted therapy and biomarkers in retinoblastoma.
- Overcoming challenges in sEV production, characterization, and clinical translation is essential for realizing their full potential.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Intralumenal Vesicles and Multivesicular Bodies
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Negative Regulator Molecules
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

